Skip to content
HowShorted

Avid Bioservices, Inc. short interest in 2020

In 2020, Avid Bioservices, Inc.'s disclosed short interest ran from 4.67% of shares outstanding on 15 Jan 2020 to 3.97% on 31 Dec 2020, a change of -0.70 percentage points. The year's high was 5.13% on 13 Mar 2020 and its low 3.04% on 15 Dec 2020, averaging 4.19% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 14.08 days on 31 Aug 2020. Full history: Avid Bioservices, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024

Aggregate net short position time series for Avid Bioservices, Inc. in 2020

2020 in figures

Start of year
4.67% (15 Jan 2020)
End of year
3.97% (31 Dec 2020)
Change
-0.70 pp
High
5.13% (13 Mar 2020)
Low
3.04% (15 Dec 2020)
Average
4.19%
Highest days to cover
14.08 (31 Aug 2020)
SEC filings marked
8

Every report in 2020

Avid Bioservices, Inc. short interest in 2020
SettlementShort interestDays to coverFilings since previous
15 Jan 20204.67%8.72
31 Jan 20204.77%9.34
14 Feb 20204.75%12.40
28 Feb 20204.85%8.24
13 Mar 20205.13%4.5410-Q filed, results (8-K)
31 Mar 20204.43%4.75
15 Apr 20204.30%10.70
30 Apr 20204.98%7.74
15 May 20203.44%5.47
29 May 20203.61%8.20
15 Jun 20203.79%6.11
30 Jun 20204.27%6.5710-K filed, results (8-K)
15 Jul 20204.52%4.61
31 Jul 20204.83%8.55
14 Aug 20204.79%8.31
31 Aug 20204.95%14.08
15 Sep 20204.52%4.3710-Q filed, results (8-K)
30 Sep 20203.42%6.09
15 Oct 20203.22%8.40
30 Oct 20203.20%9.91
13 Nov 20203.56%5.62
30 Nov 20203.66%10.42
15 Dec 20203.04%2.1910-Q filed, results (8-K)
31 Dec 20203.97%5.08

See also: Avid Bioservices, Inc.'s full history · most shorted US stocks of 2020 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.